← All candidates
36 insider filings on record.
36 filings on record.
HRMYHarmony Biosciences Holdings, Inc.
NasdaqGM · Healthcare · $2.40B
$41.54
+0.05% · Sep 14
36 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 10 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$2.40B
Float
52.1M
89% public
Short % float
Pro
Price / profit
13.3
Price / future profit
6.2
Price / sales
2.5
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
31 more transactions on Pro →Context
Wall St
$44.36 avg target
+6.8% vs today · 11 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
1 of 4 quarters beat
Q1 '26$0.79 act−$0.15
Q4 '25$0.57 act−$0.50
Q3 '25$1.08 act+$0.22
Q2 '25$0.92 act−$0.04
Coverage
Harmony Biosciences (HRMY) Stock Valuation After New Pitolisant Data And Reaffirmed GuidanceSimply Wall St. · 06-12Is Harmony Biosciences Holdings, Inc. (HRMY) A Good Stock To Buy Now?Insider Monkey · 06-11Looking Back at Stock Picks Hyatt Hotels, Sensient Technologies, Harmony Biosciences. What the Charts Say.Barrons.com · 06-04Harmony Biosciences Holdings (HRMY): One of the Best Stocks to Buy According to AI
The file stays open
36 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice